Selectis Health Q2 revenue up 91% to $11.5M; net income $1.0M vs loss year ago

SELECTIS HEALTH, INC.

Q2 2022 revenue $11.5M (record), up 91% YoY; net income $1.0M ($0.34 per share) vs net loss of $0.7M.
Q1 2022 revenue $10.1M, up 75% YoY; net income $0.2M ($0.07 per share) vs $0.2M.
Company became current on SEC filings by filing Q1 and Q2 2022 10-Qs, resolving prior delays.
Appointed Christine Lucus as CFO and David Furstenberg to board; cash $3.9M at June 30, 2022.
Operating cash flow improved to $0.1M for six months ended June 30, 2022 vs ($0.6M) year ago.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.